GSK to choose among U.K. plant sites by summer; Sanofi nabs FDA nod for head-lice lotion;

@FiercePharma: Can you imagine what Sanofi would look like now if it hadn't bought Genzyme? | Follow @FiercePharma

> GlaxoSmithKline ($GSK) says it will decide by summer among three rival sites for its new biopharmaceutical plant in the U.K. Article

> Sanofi ($SNY) won FDA approval for a new head-lice lotion, Sklice, based on the commonly used oral parasite fighter ivermectin. News

> Pfizer's ($PFE) agreement to sell its Indian animal health business to a different division is a procedural step toward hiving off its entire animal health division as planned. Report

> Reckitt Benckiser is aiming for emerging markets with its consumer health brands, restructuring the company to merge U.S. and European operations and cut costs there, while investing in faster-growing developing nations. Story

> The worldwide market for osteoporosis treatments is expected to hit $11.4 billion by 2015, a new market research report says, with $2.5 billion of the total in China. Article

> Hospira ($HSP) tapped Richard Davies as SVP and chief commercial officer, reporting to CEO F. Michael Ball. News

> CVS Caremark won a temporary restraining order that will allow it to continue selling controlled substances at two Florida pharmacies raided by the Drug Enforcement Administration. More

Biotech News

@FierceBiotech: The 25 most influential people in biopharma today. Report | Follow @FierceBiotech

@JohnCFierce: Viehbacher: "2012 has been marked red in my diary for years." More | Follow @JohnCFierce

@FierceMedDev: Merit Medical discloses warning letter regarding Merit Laureate hydrophilic guidewire. Release | Follow @FierceMedDev

> FDA rewards Roche with priority review for blockbuster cancer drug. News

> Sanofi touts R&D hopefuls as tonic for plunging profits. Story

> Illumina urges investors to shun $5.7B Roche bid. News

> Novartis vaccine Bexsero combats meningitis. Item

Drug Delivery News

> DexCom, Tandem Diabetes pursue combined CGM/insulin pump. Story

> OptiNose testing nose-to-brain delivery tech with migraine drug. More

> Report: China ramping up for global drug delivery tech battle. Article

> GW's cannabis-based mouth spray gains Austrian OK for MS spasms. News

Medical Device News

> Zimmer, ISTO start Phase III study of DeNovo tissue graft. Item

> Siemens teams up with ViiV, Tocagen on companion Dx. Article

> FDA advocates for device 'bar code' in face of OMB delay. More

> Velomedix scores $10.2M in Series B, taps new CEO. News

> Merit, PhotoMedex recipients of FDA warning letters. Piece

Biomarkers News

> Gene signature predicts cancer outcomes. More

> Heart attack? No, it's just a spinning class. Story

> Alzheimer's marker is seen in middle age. Article

> Personalized medicine grows in China with Chinese/Canadian collaboration. News

> Urine biomarker spots aggressive prostate cancer. More

And Finally... Researchers found links between genes associated with inflammation and the risk of ovarian cancer. Report

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.